AUS
NZ
UK
CA
USA
IND
Graft Polymer (UK) PLC (LSE:GPL) has appointed Dennis Purcell as the new chairman of its board. Purcell, co-founder and former managing partner of Aisling Capital, brings extensive experience in the healthcare and biopharmaceutical industries, having previously helped raise significant capital for various healthcare ventures. His expertise and connections are seen as key assets for Graft Polymer as it works to broaden its footprint in the US and European markets.
The appointment comes as Graft Polymer focuses on advancing its therapies for mental health and substance use disorders. With a collaborative approach that includes partnerships such as the one with Awakn, the company aims to make a substantial impact in the biopharmaceutical space, targeting areas where there is growing demand for innovative treatments.
Purcell replaces Nicholas Nelson, who will remain with the company as a non-executive director. Commenting on his new role, Purcell expressed optimism about Graft Polymer’s potential to drive growth and develop transformative solutions for patients. “The company’s collaboration model, starting with Awakn, is poised to make a significant impact in the biopharmaceutical sector—specifically in the area of treating addiction and mental health issues,” Purcell said in a statement.
Nicholas Nelson welcomed the leadership transition, highlighting Purcell’s experience as a pivotal addition. “Having now reached an inflection point, it is time to welcome Dennis to lead the board,” Nelson stated. “His appointment speaks volumes about what Graft Polymer is doing, and I am confident that his expertise in biotech and capital markets will be instrumental in steering the company towards success.”
The leadership change is seen as a strategic move to bolster Graft Polymer’s position in the industry and accelerate its path to delivering new solutions. With Purcell’s guidance, the company looks set to enhance its presence and bring forward innovative treatments that address unmet needs in the mental health and addiction treatment spaces.
